Publicacións en colaboración con investigadores/as de Centro de Investigación Cooperativa en Biotecnología (31)

2024

  1. SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells

    Cellular and Molecular Biology Letters, Vol. 29, Núm. 1

  2. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

    Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182

  3. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. A tetracationic porphyrin with dual anti-prion activity

    iScience, Vol. 26, Núm. 9

  3. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

    Nature Communications, Vol. 14, Núm. 1

  4. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

  5. Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function

    Molecular Metabolism, Vol. 75

  6. Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 10

  7. Understanding the key features of the spontaneous formation of bona fide prions through a novel methodology that enables their swift and consistent generation

    Acta Neuropathologica Communications, Vol. 11, Núm. 1

2022

  1. Angiocrine polyamine production regulates adiposity

    Nature Metabolism, Vol. 4, Núm. 3, pp. 327-343

  2. Bona fide atypical scrapie faithfully reproduced for the first time in a rodent model

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

  3. Implication of Ceramide Kinase/C1P in Cancer Development and Progression

    Cancers, Vol. 14, Núm. 1

  4. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24

  5. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis

    Journal of Hepatology, Vol. 77, Núm. 1, pp. 15-28

2021

  1. O-GlcNAcylated p53 in the liver modulates hepatic glucose production

    Nature Communications, Vol. 12, Núm. 1

  2. The L-α-Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis

    Hepatology, Vol. 73, Núm. 2, pp. 606-624

2020

  1. Dissection of the key steps of amyloid-β peptide 1–40 fibrillogenesis

    International Journal of Biological Macromolecules, Vol. 164, pp. 2240-2246

2019

  1. Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies

    PLoS Pathogens, Vol. 15, Núm. 10

  2. Proteomic studies reveal disrupted in schizophrenia 1 as a player in both neurodevelopment and synaptic function

    International Journal of Molecular Sciences, Vol. 20, Núm. 1